{"entity":{"id":"shanghai-sunway-biotech","kind":"company","name":"Shanghai Sunway Biotech","aka":["Sunway Biotech"],"tldr":"Shanghai Sunway Biotech makes Oncorine (H101), the oncolytic adenovirus approved in China in 2005, the first oncolytic virus approved anywhere.","summary":"Shanghai Sunway Biotech developed and manufactures H101 (Oncorine), an E1B-deleted oncolytic adenovirus approved by China's regulator in November 2005 for late-stage nasopharyngeal carcinoma with chemotherapy. It remains the only approved oncolytic virus in China and is being studied in liver and other cancers.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.sunwaybio.com.cn"}],"tags":["ctgov-sponsor","china"],"related":[],"cancers":["nasopharyngeal"],"sections":[],"technologies":["oncolytic-virus"],"targets":[],"drugs":["h101-oncolytic-adenovirus"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"Shanghai, China","country":"CN","companyType":"biotech","website":"https://www.sunwaybio.com.cn","stage":"private-large","investors":[],"funding":[]},"route":"/companies/shanghai-sunway-biotech/","neighbours":{"cancer":[{"id":"nasopharyngeal","kind":"cancer","name":"Nasopharyngeal carcinoma","route":"/cancers/nasopharyngeal/"}],"technology":[{"id":"oncolytic-virus","kind":"technology","name":"Oncolytic viruses","route":"/technologies/oncolytic-virus/"}],"drug":[{"id":"h101-oncolytic-adenovirus","kind":"drug","name":"H101 oncolytic adenovirus","route":"/drugs/h101-oncolytic-adenovirus/"}]}}